The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to BharatBiotech's COVAXIN for children between the age of 6-12 years, news agency ANI tweeted on Tuesday citing sources.
DCGI has also granted emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children above the age of 12 years and emergency use authorisation to Corbevax for children between the age of 5-12 years, the news agency has said in a series of tweets.